Name: BIOTEST AG (BIO) Stock
Brand: BIOTEST AG
Rating: 4 (3 reviews)

Question 1

What does BIO do?

Accepted Answer

Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees.  Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Question 2

What is the stock price of BIOTEST AG today?

Accepted Answer

The current stock price of BIO.DE is 42.2 EUR. The price decreased by -0.94% in the last trading session.

Question 3

Does BIO stock pay dividends?

Accepted Answer

BIOTEST AG (BIO.DE) has a dividend yield of 0.09%. The yearly dividend amount is currently 0.04.

Question 4

What is the ChartMill technical and fundamental rating of BIO stock?

Accepted Answer

BIO.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.

Question 5

What is the Price/Earnings (PE) ratio of BIOTEST AG (BIO.DE)?

Accepted Answer

BIOTEST AG (BIO.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.65).

Question 6

Would investing in BIOTEST AG be a good decision?

Accepted Answer

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BIO.DE.

BIOTEST AG (BIO.DE) Stock Price, Forecast & Analysis

BIO.DE Latest News, Press Relases and Analysis